2Annane D,Sebille V,Troche G,et al.A3-level prognos-tic classification in sepsis shock based on cortisol level and cortisol response to corticotropin.[J].JAMA,2000,283(8):1038-1045.
1[1]Bone ND,Roger C.Risk distributions of 519 ICU adnission for sepsis according to the definition of SIRS[J].Chest, 1992,101(6):1481-1483.
2[2]Tracey KJ,Lowry SF,Cerami A.Cachetin/TNF-alpha in septic shock and septic adult respirate distress syndrome[J].Am Rev Respir Dis,1998,138(6):1377-1379.
3[3]Hawkins DL,Mackay RJ,Mackay SL,et al.Human TGF-beta and interleukin-10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages[J].Vet Immunol Immunopathol,1998,66(1):1-10.
4[4]Pinsky MR,Vincent JL,Deviere J,et al.Serum cytokine levels in human septic shock:relation to multiple-system organ failure and mortality[J].Chest,1993,103:565-569.
5[5]Walley KR,Lukacs NW,Standiford TJ,et al.Balance of inflammatory cytokines related to severity and mortality of murine sepsis[J].Infect Immun,1996,64(11):4733-4738.
6Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care.Crit Care Med,2001,29:1303-1310.
7Dellinger PR,Carlet JM,Gerlach H,et al.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Crit Care Med,2004,32:858-873.
8Levy M,Pronovost P,Dellinger P,et al.Sepsis change bundles:Converting guidelines into meaningfulchange in behavior and clinical outcome.Crit Care Med,2004,32:s595-s597.
9Kalhan R,Mikkelsen M,Dedhiya P,et al.Underuse of lung protective ventilation:analysis of potential factors to explain physician behavior.Crit Care Med,2006,34:300-306.
10Levy M.Finding out what we do in the ICU.Crit Care Med,2006,34:227-228.
